Stanford scientists have resurrected a discarded drug that helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.
Chemical engineers at Stanford have discovered mechanical properties of the tear film on the eye's surface that can be used to manufacture contact lenses that more closely mimic the eye.
Catching a disease in its earliest stages can lead to more effective therapies. Stanford chemists have increased the likelihood of detecting these diseases via a test that is thousands of times more sensitive than current diagnostics.
Using two decades of HIV data, Stanford scientists found that effective treatment caused the virus to evolve differently than less effective treatments. They hope this insight will improve testing of new drugs.
A team of bioengineers and physicians has found that the squishiness of an hour-old fertilized egg can predict its viability, a metric that could lead to safer, more successful IVF pregnancies.
Stanford researchers manipulated the brains of morphine-addicted mice and allowed the animals to overcome withdrawal symptoms. The finding could offer a new approach to quieting symptoms that often lead to recurring drug use.
Recently named interim president and CEO of Stanford Health Care, Mariann Byerwalter talks about why this is a particularly exciting time for SHC as it builds a new hospital and pursues innovative breakthroughs that improve people's lives.
